Indaptus Therapeutics, Inc. (INDP) Tops Q3 EPS by 16c

Indaptus Therapeutics, Inc. (NASDAQ: INDP) reported Q3 EPS of ($0.32), $0.16 better than the analyst estimate of ($0.48).

For earnings history and earnings-related data on Indaptus Therapeutics, Inc. (INDP) click here.

You May Also Be Interested In

• Bessent on bonds: buyback could be more than 4 billion - CNBC
• Rubrik Inc (RBRK) PT Raised to $120 at Cantor Fitzgerald Into Q2 Earnings
• UBS Reiterates Buy Rating on Dutch Bros Inc. (BROS): 'One of Strongest Growth Stories in Restaurants'